DK1221952T3 - Anvendelse af en antagonist til centrale cannaboidreceptorer med henblik på fremstilling af lægemidler - Google Patents
Anvendelse af en antagonist til centrale cannaboidreceptorer med henblik på fremstilling af lægemidlerInfo
- Publication number
- DK1221952T3 DK1221952T3 DK00966200T DK00966200T DK1221952T3 DK 1221952 T3 DK1221952 T3 DK 1221952T3 DK 00966200 T DK00966200 T DK 00966200T DK 00966200 T DK00966200 T DK 00966200T DK 1221952 T3 DK1221952 T3 DK 1221952T3
- Authority
- DK
- Denmark
- Prior art keywords
- cannaboid
- antagonist
- receptors
- drugs
- manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Virology (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9912415A FR2799124B1 (fr) | 1999-10-01 | 1999-10-01 | Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments |
PCT/FR2000/002662 WO2001024798A1 (fr) | 1999-10-01 | 2000-09-27 | Utilisation d'un antagoniste des recepteurs aux cannabinoïdes centraux pour la preparation de medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1221952T3 true DK1221952T3 (da) | 2005-08-29 |
Family
ID=9550596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00966200T DK1221952T3 (da) | 1999-10-01 | 2000-09-27 | Anvendelse af en antagonist til centrale cannaboidreceptorer med henblik på fremstilling af lægemidler |
Country Status (12)
Country | Link |
---|---|
US (1) | US6642258B1 (da) |
EP (1) | EP1221952B1 (da) |
JP (1) | JP2003510361A (da) |
AR (1) | AR025883A1 (da) |
AT (1) | ATE295170T1 (da) |
AU (1) | AU7667300A (da) |
DE (1) | DE60020145T2 (da) |
DK (1) | DK1221952T3 (da) |
ES (1) | ES2240176T3 (da) |
FR (1) | FR2799124B1 (da) |
PT (1) | PT1221952E (da) |
WO (1) | WO2001024798A1 (da) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7129239B2 (en) | 2002-10-28 | 2006-10-31 | Pfizer Inc. | Purine compounds and uses thereof |
US7247628B2 (en) | 2002-12-12 | 2007-07-24 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
US7329658B2 (en) | 2003-02-06 | 2008-02-12 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
US7176210B2 (en) | 2003-02-10 | 2007-02-13 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
US7268133B2 (en) | 2003-04-23 | 2007-09-11 | Pfizer, Inc. Patent Department | Cannabinoid receptor ligands and uses thereof |
US7145012B2 (en) | 2003-04-23 | 2006-12-05 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
JP2007501279A (ja) * | 2003-05-20 | 2007-01-25 | ユニバーシティ・オブ・テネシー・リサーチ・ファウンデイション | カンナビノイド誘導体、その製造方法、および使用 |
US7232823B2 (en) | 2003-06-09 | 2007-06-19 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
FR2861303A1 (fr) * | 2003-10-24 | 2005-04-29 | Sanofi Synthelabo | Utilisation d'un derive de pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du syndrome metabolique |
WO2006060192A2 (en) * | 2004-11-30 | 2006-06-08 | Bayer Pharmaceuticals Corporation | Pyrazole derivatives |
ES2435790T3 (es) | 2004-12-03 | 2013-12-23 | Intervet International B.V. | Piperazinas sustituidas como antagonistas de CB1 |
US9289583B2 (en) | 2006-01-06 | 2016-03-22 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US8252328B2 (en) | 2006-01-06 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US8357114B2 (en) | 2006-01-06 | 2013-01-22 | Acelrx Pharmaceuticals, Inc. | Drug dispensing device with flexible push rod |
US8252329B2 (en) | 2007-01-05 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US8202535B2 (en) | 2006-01-06 | 2012-06-19 | Acelrx Pharmaceuticals, Inc. | Small-volume oral transmucosal dosage forms |
US8753308B2 (en) | 2006-01-06 | 2014-06-17 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US8535714B2 (en) | 2006-01-06 | 2013-09-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US8865743B2 (en) | 2006-01-06 | 2014-10-21 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US9066847B2 (en) * | 2007-01-05 | 2015-06-30 | Aceirx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
CA2637565A1 (en) | 2006-01-18 | 2007-07-26 | Schering Corporation | Cannibinoid receptor modulators |
WO2008130616A2 (en) * | 2007-04-19 | 2008-10-30 | Schering Corporation | Diaryl morpholines as cb1 modulators |
BRPI0814806A2 (pt) * | 2007-06-28 | 2015-02-03 | Intervet Int Bv | Pirazinas substituídas como antagonistas de cb1 |
JP2010531874A (ja) * | 2007-06-28 | 2010-09-30 | インターベット インターナショナル ベー. フェー. | Cb1アンタゴニストとしての置換ピペラジン |
ES2534433T3 (es) * | 2007-08-07 | 2015-04-22 | Acelrx Pharmaceuticals, Inc. | Composiciones que comprenden sufentanilo y triazolam para sedación y analgesia operatorias utilizando formas farmacéuticas transmucosas orales |
US8945592B2 (en) * | 2008-11-21 | 2015-02-03 | Acelrx Pharmaceuticals, Inc. | Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
US20110091544A1 (en) * | 2009-10-16 | 2011-04-21 | Acelrx Pharmaceuticals, Inc. | Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting |
WO2013068371A1 (en) | 2011-11-08 | 2013-05-16 | Intervet International B.V. | Soft chewable dosage form compositions of cannabinoid receptor type 1 (cb-1) antagonists |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2692575B1 (fr) * | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
FR2713225B1 (fr) * | 1993-12-02 | 1996-03-01 | Sanofi Sa | N-pipéridino-3-pyrazolecarboxamide substitué. |
US5596106A (en) * | 1994-07-15 | 1997-01-21 | Eli Lilly And Company | Cannabinoid receptor antagonists |
DE19706903A1 (de) * | 1997-02-21 | 1998-08-27 | Bayer Ag | Verwendung von bekannten Agonisten des zentralen Cannabinoid-Rezeptors CB 1 |
FR2783246B1 (fr) * | 1998-09-11 | 2000-11-17 | Aventis Pharma Sa | Derives d'azetidine, leur preparation et les medicaments les contenant |
FR2789079B3 (fr) | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant |
-
1999
- 1999-10-01 FR FR9912415A patent/FR2799124B1/fr not_active Expired - Fee Related
-
2000
- 2000-09-27 WO PCT/FR2000/002662 patent/WO2001024798A1/fr active IP Right Grant
- 2000-09-27 AU AU76673/00A patent/AU7667300A/en not_active Abandoned
- 2000-09-27 AT AT00966200T patent/ATE295170T1/de not_active IP Right Cessation
- 2000-09-27 PT PT00966200T patent/PT1221952E/pt unknown
- 2000-09-27 ES ES00966200T patent/ES2240176T3/es not_active Expired - Lifetime
- 2000-09-27 US US10/088,704 patent/US6642258B1/en not_active Expired - Fee Related
- 2000-09-27 DK DK00966200T patent/DK1221952T3/da active
- 2000-09-27 EP EP00966200A patent/EP1221952B1/fr not_active Expired - Lifetime
- 2000-09-27 DE DE60020145T patent/DE60020145T2/de not_active Expired - Lifetime
- 2000-09-27 JP JP2001527797A patent/JP2003510361A/ja not_active Withdrawn
- 2000-09-28 AR ARP000105103A patent/AR025883A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
ES2240176T3 (es) | 2005-10-16 |
PT1221952E (pt) | 2005-08-31 |
AU7667300A (en) | 2001-05-10 |
AR025883A1 (es) | 2002-12-18 |
EP1221952A1 (fr) | 2002-07-17 |
FR2799124B1 (fr) | 2004-08-13 |
JP2003510361A (ja) | 2003-03-18 |
EP1221952B1 (fr) | 2005-05-11 |
ATE295170T1 (de) | 2005-05-15 |
US6642258B1 (en) | 2003-11-04 |
FR2799124A1 (fr) | 2001-04-06 |
WO2001024798A1 (fr) | 2001-04-12 |
DE60020145D1 (de) | 2005-06-16 |
DE60020145T2 (de) | 2006-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1221952T3 (da) | Anvendelse af en antagonist til centrale cannaboidreceptorer med henblik på fremstilling af lægemidler | |
PT1131291E (pt) | Antagonistas iii do receptor 4-aroil-piperidin-ccr-3 | |
PT1009732E (pt) | 1-amino-alquilciclo-hexanos antagonistas do receptor nmda | |
DK1257275T3 (da) | Anvendelse af en antagonist til centrale cannabiboidreceptorer til fremstilling af lægemidler, der er nyttige for at göre det lettere at ophöre med brug af tobak | |
CY2010003I1 (el) | Αγωνιστες των βητα-2 αδρενεργικων υποδοχεων | |
DE60026169D1 (de) | Selektive neurokinin-antagonisten | |
ATE368659T1 (de) | Thrombinrezeptorantagonisten | |
PT1224174E (pt) | Derivados de benzodiazepina como antagonistas do receptor metabotropico do glutamato | |
PT1347760E (pt) | Composicoes farmaceuticas de agonista do receptor de nmda | |
NO20004503L (no) | Vitronectin-reseptor-antagonister | |
NO20013997D0 (no) | Reseptoranalyse | |
NO20015779D0 (no) | Bradykinin-reseptorantagonister | |
NO20016077L (no) | Makrofag-oppfanger-reseptorantagonister | |
IT1316831B1 (it) | Dispositivo per il collegamento di due parti costruttive | |
DK1475379T3 (da) | Anvendelse af scopinesterderivater til fremstilling af lægemidler | |
DE60130000D1 (de) | Zwitterionische tachykinin-rezeptor-antagonisten | |
PT1171419E (pt) | Derivados de bifenilo como antagonistas do receptor da neuroquinina-1 | |
DE69920518D1 (de) | Vitronectin rezeptor antagonist | |
NO20021113D0 (no) | Vitronectin-reseptor-antagonister | |
NO20021295L (no) | Nikotinsyreacetylcholin-reseptor | |
NO20010620D0 (no) | Vitronektinreseptor-antagonister | |
DK1385512T3 (da) | Anvendelse af pyridoindolonderivater til fremstilling af anticancerlægemidler | |
ATE320254T1 (de) | Crf receptor antagonisten | |
ATE401068T1 (de) | Il-9 receptor-antagonisten | |
SE0003996D0 (sv) | Receptorantagonister |